Stock to Sell #6 – Merck & Co. (MRK)
Merck & Co. (NYSE:MRK) is one of the world’s largest drug makers. Analysts note that the company has a number of promising drugs in its “pipeline” that could have an impact on earnings next year, but approvals have been slow. BOA Merrill Lynch recently downgraded its rating to “neutral.”
A break below $43 could result in a pullback to the low $30s. Historically MRK has been a slow-growing stock, thus it should be sold and the money repositioned into a better-performing investment.